Log In
Print
BCIQ
Print
Print this Print this
 

Fabrazyme, agalsidase beta

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionAgalsidase beta
Molecular Target Not available
Mechanism of ActionEnzyme replacement therapy
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentMarketed
Standard IndicationFabry's disease
Indication DetailsTreat Fabry's disease
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today